{"id":109094,"date":"2023-09-06T12:12:15","date_gmt":"2023-09-06T06:42:15","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=109094"},"modified":"2023-09-06T12:12:20","modified_gmt":"2023-09-06T06:42:20","slug":"pharma-stocks-with-net-profit-margin-of-up-to-64-to-add-to-your-watchlist","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stocks-with-net-profit-margin-of-up-to-64-to-add-to-your-watchlist\/","title":{"rendered":"Pharma stocks with net profit margin of up to 64% to add to your watchlist"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-362100457\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>The players involved in the Pharmaceutical industry, a capital-intensive one, strive hard to maintain average margin ratios such as the net profit margin, atleast matching those of others present in the segment.&nbsp;<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-2338432281\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><p>Listed below are three stocks that have a Net Profit Margin of more than xx percent during FY2022-2023:&nbsp;<\/p><h4 class=\"wp-block-heading\" id=\"h-caplin-point-laboratories-limited\"><strong><a href=\"https:\/\/portal.tradebrains.in\/stock\/CAPLIPOINT\/consolidated\" target=\"_blank\" rel=\"noreferrer noopener\">Caplin Point Laboratories Limited<\/a>&nbsp;<\/strong><\/h4><p>With a market capitalization of Rs 8,393.72 crores, the stocks of Caplin Point Laboratories Limited, associated with the manufacturing of pharmaceutical products including capsules, dry powder, soft gels, etc, are currently trading at Rs 1,105.40, slipping around 0.80 percent as compared to the previous closing levels of Rs 1,113.95 apiece.\u00a0<\/p><p>In recent years, the company has been successful in increasing its operating revenues as well as after-tax profits with the former moving up from Rs 1,269 crores during FY21-22 to Rs 1,466 crores during FY22-23, and, the latter, during the same timeframe, taking a shift from Rs 308 crores to Rs 376 crores.&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-149840746\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>In addition to the above, the company reported a net profit <strong>margin of 25.69 percent<\/strong> during FY2022-2023.&nbsp;<\/p><h4 class=\"wp-block-heading\"><strong><a href=\"https:\/\/portal.tradebrains.in\/stock\/SUVENPHAR\/consolidated\" target=\"_blank\" rel=\"noreferrer noopener\">Suven Pharmaceuticals Limited<\/a>&nbsp;<\/strong><\/h4><p>With a market capitalization of Rs 13,035 crores, the stocks of Suven Pharmaceuticals Limited, engaged in the business of developing as well as manufacturing specialty chemicals, etc, are currently trading at Rs 512.05, gaining around 0.95 percent as compared to the previous closing levels of Rs 507.35 apiece.&nbsp;<\/p><p>In addition to the above, the company reported a net profit <strong>margin of 30.68 percent<\/strong> during FY2022-2023.&nbsp;<\/p><h4 class=\"wp-block-heading\"><strong><a href=\"https:\/\/portal.tradebrains.in\/stock\/ALEMBICLTD\/consolidated\" target=\"_blank\" rel=\"noreferrer noopener\">Alembic Limited<\/a>&nbsp;<\/strong><\/h4><p>With a market capitalization of Rs 2,136.42 crores, the stocks of Alembic Limited, engaged in the business of manufacturing Active Pharmaceutical Ingredients (APIs), are currently trading at Rs 83.20, slipping around 1.80 percent as compared to the previous closing levels of Rs 84.66 apiece.<\/p><p>In recent years, the company has been successful in increasing its operating revenues from Rs crores during FY21-22 to Rs crores during FY22-23. On the contrary, the after-tax profits of the company took a marginal downshift from Rs 86 crores to Rs 80 crores.&nbsp;<\/p><p>In addition to the above, the company reported a net profit <strong>margin of 63.35 percent<\/strong> during FY2022-2023.\u00a0<\/p><div class=\"trade-content-10\" id=\"trade-2770320390\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_3_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"2969612066\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written by Amit Madnani<\/strong><\/p><\/blockquote><h4 class=\"wp-block-heading\"><strong>Disclaimer<\/strong><\/h4><div class=\"wp-block-image\"><figure class=\"aligncenter size-medium\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.<\/strong><\/p><div class=\"trade-after-content\" id=\"trade-2484704970\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>The players involved in the Pharmaceutical industry, a capital-intensive one, strive hard to maintain average margin ratios such as the net profit margin, atleast matching those of others present in the segment.&nbsp; Listed below are three stocks that have a Net Profit Margin of more than xx percent during FY2022-2023:&nbsp; Caplin Point Laboratories Limited&nbsp; With [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":82826,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[11744,11743,10597,10596,3047,11745,948,936,11742],"class_list":["post-109094","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-alembic-limited-latest-news","tag-alembic-limited-share-price","tag-caplin-point-laboratories-latest-news","tag-caplin-point-laboratories-share-price","tag-pharma-stocks","tag-pharma-stocks-2023","tag-stock-market","tag-stock-market-news","tag-suven-pharmaceuticals-share-price"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stocks with net profit margin of up to 64% to add to your watchlist - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"The players involved in the Pharmaceutical industry, a capital-intensive one, strive hard to maintain average margin ratios such as the net profit margin, atleast matching those of others present in the segment.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stocks-with-net-profit-margin-of-up-to-64-to-add-to-your-watchlist\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stocks with net profit margin of up to 64% to add to your watchlist\" \/>\n<meta property=\"og:description\" content=\"The players involved in the Pharmaceutical industry, a capital-intensive one, strive hard to maintain average margin ratios such as the net profit margin, atleast matching those of others present in the segment.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stocks-with-net-profit-margin-of-up-to-64-to-add-to-your-watchlist\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-06T06:42:15+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-09-06T06:42:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/pharma-cover-image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stocks-with-net-profit-margin-of-up-to-64-to-add-to-your-watchlist\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stocks-with-net-profit-margin-of-up-to-64-to-add-to-your-watchlist\/\",\"name\":\"Pharma stocks with net profit margin of up to 64% to add to your watchlist - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stocks-with-net-profit-margin-of-up-to-64-to-add-to-your-watchlist\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stocks-with-net-profit-margin-of-up-to-64-to-add-to-your-watchlist\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/pharma-cover-image.jpg\",\"datePublished\":\"2023-09-06T06:42:15+00:00\",\"dateModified\":\"2023-09-06T06:42:20+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"The players involved in the Pharmaceutical industry, a capital-intensive one, strive hard to maintain average margin ratios such as the net profit margin, atleast matching those of others present in the segment.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stocks-with-net-profit-margin-of-up-to-64-to-add-to-your-watchlist\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stocks-with-net-profit-margin-of-up-to-64-to-add-to-your-watchlist\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stocks-with-net-profit-margin-of-up-to-64-to-add-to-your-watchlist\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/pharma-cover-image.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/pharma-cover-image.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stocks-with-net-profit-margin-of-up-to-64-to-add-to-your-watchlist\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stocks with net profit margin of up to 64% to add to your watchlist\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stocks with net profit margin of up to 64% to add to your watchlist - Trade Brains Features","description":"The players involved in the Pharmaceutical industry, a capital-intensive one, strive hard to maintain average margin ratios such as the net profit margin, atleast matching those of others present in the segment.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stocks-with-net-profit-margin-of-up-to-64-to-add-to-your-watchlist\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stocks with net profit margin of up to 64% to add to your watchlist","og_description":"The players involved in the Pharmaceutical industry, a capital-intensive one, strive hard to maintain average margin ratios such as the net profit margin, atleast matching those of others present in the segment.\u00a0","og_url":"https:\/\/tradebrains.in\/features\/pharma-stocks-with-net-profit-margin-of-up-to-64-to-add-to-your-watchlist\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2023-09-06T06:42:15+00:00","article_modified_time":"2023-09-06T06:42:20+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/pharma-cover-image.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stocks-with-net-profit-margin-of-up-to-64-to-add-to-your-watchlist\/","url":"https:\/\/tradebrains.in\/features\/pharma-stocks-with-net-profit-margin-of-up-to-64-to-add-to-your-watchlist\/","name":"Pharma stocks with net profit margin of up to 64% to add to your watchlist - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stocks-with-net-profit-margin-of-up-to-64-to-add-to-your-watchlist\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stocks-with-net-profit-margin-of-up-to-64-to-add-to-your-watchlist\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/pharma-cover-image.jpg","datePublished":"2023-09-06T06:42:15+00:00","dateModified":"2023-09-06T06:42:20+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"The players involved in the Pharmaceutical industry, a capital-intensive one, strive hard to maintain average margin ratios such as the net profit margin, atleast matching those of others present in the segment.\u00a0","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stocks-with-net-profit-margin-of-up-to-64-to-add-to-your-watchlist\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stocks-with-net-profit-margin-of-up-to-64-to-add-to-your-watchlist\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stocks-with-net-profit-margin-of-up-to-64-to-add-to-your-watchlist\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/pharma-cover-image.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/pharma-cover-image.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stocks-with-net-profit-margin-of-up-to-64-to-add-to-your-watchlist\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stocks with net profit margin of up to 64% to add to your watchlist"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/109094","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=109094"}],"version-history":[{"count":2,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/109094\/revisions"}],"predecessor-version":[{"id":109100,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/109094\/revisions\/109100"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/82826"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=109094"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=109094"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=109094"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}